Recent Genetic Discoveries Don t Improve Prediction of Breast Cancer: related news

Recent Genetic Discoveries Don't Improve Prediction of Breast Cancer

FRIDAY, July 11 (HealthDay News) — The accuracy of predicting one's chances of developing breast cancer do not seem to improve even with the recent findings of some genetic markers for the disease, a new report says.

Recent Genetic Discoveries Don't Improve Prediction of Breast Cancer

FRIDAY, July 11 (HealthDay News) -- The accuracy of predicting one's chances of developing breast cancer do not seem to improve even with the recent findings of some genetic markers for the disease, a new report says.

Recent Genetic Discoveries Don't Improve Prediction of Breast Cancer

FRIDAY, July 11 (HealthDay News) -- The accuracy of predicting one's chances of developing breast cancer do not seem to improve even with the recent findings of some genetic markers for the disease, a new report says.

Recent Genetic Discoveries Don't Improve Prediction of Breast Cancer

FRIDAY, July 11 (HealthDay News) -- The accuracy of predicting one's chances of developing breast cancer do not seem to improve even with the recent findings of some genetic markers for the disease, a new report says.

Recent Genetic Discoveries Don't Improve Prediction of Breast Cancer

FRIDAY, July 11 (HealthDay News) -- The accuracy of predicting one's chances of developing breast cancer do not seem to improve even with the recent findings of some genetic markers for the disease, a new report says.

Recent Genetic Discoveries Don't Improve Prediction of Breast Cancer

FRIDAY, July 11 (HealthDay News) -- The accuracy of predicting one's chances of developing breast cancer do not seem to improve even with the recent findings of some genetic markers for the disease, a new report says.

Genetic link between Crohn's and asthma discovered

Add our medical news to digg - Genetic link between Crohn's and asthma discovered Add our medical news to NewsVine - Genetic link between Crohn's and asthma discovered Add our medical news to Fark - Genetic link between Crohn's and asthma discovered Add our medical news to Furl - Genetic link between Crohn's and asthma discovered Add our medical news to Shadows - Genetic link between Crohn's and asthma discovered Add our medical news to YahooMyWeb - Genetic link between Crohn's and asthma discovered Add our medical news to Reddit -Genetic link between Crohn's and asthma discovered Add our medical news to StumbleUpon - Genetic link between Crohn's and asthma discovered Add our medical news to Facebook - Genetic link between Crohn's and asthma discovered

Patent bid sparks cancer-test price fears

A decision by Genetic Technologies could make breast cancer examinations more expensive, according to Cancer Australia. Genetic holds the Australian and New Zealand patent licences for a test that detects mutations in breast cancer genes, and recently announced plans to use its patent rights to conduct all future testing itself. Women with the defective gene have an 85 per cent change of contracting the disease, against a community-wide average of around nine per cent. Cancer Council Australia CEO, Ian Olver, said allowing genes to be patented could be problematic in the long term and could compromise the Human Genome Project

Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis

(PHILADELPHIA) Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have made a key discovery about the mechanism of breast cancer metastasis, the process by which cancer spreads. Focusing on a gene dubbed "Dachshund," or DACH1, they are beginning to pinpoint new therapeutic targets to halt the spread of cancer.

Breast cancer art comp

The NSW Breast Cancer Institute is inviting breast cancer survivors and their family and friends to enter the Life After Five art competition.

Discovery of major genetic cause of colorectal cancer

Add our medical news to StumbleUpon - Discovery of major genetic cause of colorectal cancer Add our medical news to Facebook - Discovery of major genetic cause of colorectal cancer

Cancer Resistance Technique Moves To Human Trials

TaeKwonDood tips us to news that a new cancer resistance treatment is going into clinical trials after being quite successful at eradicating cancer in mice. Researchers discovered that certain white blood cells called granulocytes from cancer-immune mice were able to cure cancer in other mice. Now, doctors are putting out the call for healthy granulocyte donors in order to test how well it works on humans. The article quotes lead researcher Zheng Cui saying, "In mice, we've been able to eradicate even highly aggressive forms of malignancy with extremely large tumors. Hopefully, we will see the same results in humans. Our laboratory studies indicate that this cancer-fighting ability is even stronger in healthy humans."

LegalView Informs Mesothelioma Blog Readers of A New Clinical Trial Available for Victims of Asbestos-Induced Lung Cancer

blog on an opportunity for pleural mesothelioma cancer victims to participate in a clinical trial being conducted at the Mesothelioma Center at New York-Presbyterian Hospital and Columbia University Medical Center. The clinical trial hopes to improve surgical and radiation treatments for patients of pleural mesothelioma cancer. Currently, the most common treatment for patients of the asbestos-induced cancer is removal of the victim's lung. Individuals who suffer from pleural mesothelioma or any other form of mesothelioma cancer are advised to speak with an experienced

LegalView Informs Mesothelioma Blog Readers of A New Clinical Trial Available for Victims of Asbestos-Induced Lung Cancer

(EMAILWIRE.COM, July 08, 2008 ) Denver, CO - LegalView.com, the number one legal resource on the Web, offered information through its mesothelioma information (http://mesothelioma.legalview.com/blog ) blog on an opportunity for pleural mesothelioma cancer victims to participate in a clinical trial being conducted at the Mesothelioma Center at New York-Presbyterian Hospital and Columbia University Medical Center. The clinical trial hopes to improve surgical and radiation treatments for patients of pleural mesothelioma cancer. Currently, the most common treatment for patients of the asbestos-induced cancer is removal of the victim's lung. Individuals who suffer from pleural mesothelioma or any other form of mesothelioma cancer are advised to speak with an experienced mesothelioma lawyer (http://mesothelioma.

Genetic Factor in Colon Cancer Discovered

Researchers have discovered an abnormality in a gene that they have strongly linked to the development of inherited colon cancer, which may account for up to 20 percent of cases of colon cancer. As VOA's Jessica Berman reports, scientists believe the discovery could lead to a simple blood test to identify people susceptible to inherited colon cancer.

Where To Draw the Line With Embryo Selection?

Tjeerd writes "There is currently a discussion going on in the Netherlands about embryo selection. The process means that when using in vitro fertilization, you can check what kind of genetic defects will definitely become activated during life. When embryos with those defects are identified, they can be avoided or destroyed. The next step the government is considering is to make it possible to select against genetic defects which might become active in life, such as breast and colon cancer. Of course, this is a very difficult discussion; where do you start, and where do you end? People are worrying that there is no real limit, and that you could potentially check for every genetic defect. I think if you're in a situation where you or your family have genetic defects, you surely want to check whether your children would have them too.

We Predict a Google Genetic Map

Over at Genetic Future, Daniel MacArthur discusses the recent Lao paper from Current Biology that genotyped 2,514 people from 23 different European subpopulations. The researchers looked at 300,000 genetic markers and constructed a genetic map -- one that MacArthur says can nearly tell you your postcode. "The accuracy of the map will have been limited by the fact that the markers used in this study represent sites of common variation; data from large-scale genome sequencing will generate far, far better maps," writes MacArthur.

HotHardware's Recent Blogs and Video Channel

Just in case you have missed some of the recent additions to HotHardware.com, we wanted to draw your attention to a couple of new sections on the site that are sure to be of interest to many of you. You'll notice on the home page, a couple of tabs have been added to main content area labeled Recent Blogs and Recent Videos. There are also couple of new buttons in the main navigation bar under the logo at the top of every page of the site. As their names imply, those tabs and buttons with take you to recent blog posts from the HotHardware staff or the latest video spotlights that will accompany our written content.

CSS dos and don'ts

When you're looking at lists of dos and don'ts for CSS you usually think of just the CSS selectors, using external style sheets, and other aspects of the CSS. But as CSS Globe points out, structuring your HTML markup is just as important as the CSS. These CSS dos and don'ts for markup are great suggestions for how to improve your code. One I think more people should keep in mind is "don't think that if something is valid it is automatically web standards compliant."

Olympic Gold Medalist Inspires Cancer Patients Through Blog

BEIJING, August 18, 2008 /PRNewswire/ -- Dick Fosbury, gold medalist from the 1968 Olympic Games in Mexico City and innovator of the high jump technique dubbed the "Fosbury Flop," which revolutionized the sport and is now considered its standard, was stricken by cancer lymphoma in March. After undergoing surgery, radiation and chemotherapy treatment at the Cancer Center, the State of New Mexico's Official Cancer Center based on the UNM campus in Albuquerque, NM, Fosbury is currently attending the 2008 Olympics Games in Beijing to celebrate the 40th anniversary of the "Fosbury Flop" and inspire cancer patients throughout the world.

Olympic Gold Medalist Inspires Cancer Patients Through Blog

BEIJING, Aug. 18 /PRNewswire/ -- Dick Fosbury, gold medalist from the 1968 Olympic Games in Mexico City and innovator of the high jump technique dubbed the "Fosbury Flop," which revolutionized the sport and is now considered its standard, was stricken by cancer lymphoma in March. After undergoing surgery, radiation and chemotherapy treatment at the University of New Mexico Cancer Center, the State of New Mexico's Official Cancer Center based on the UNM campus in Albuquerque, NM, Fosbury is currently attending the 2008 Olympics Games in Beijing to celebrate the 40th anniversary of the "Fosbury Flop" and inspire cancer patients throughout the world.

Olympic Gold Medalist Inspires Cancer Patients Through Blog

BEIJING, Aug 18, 2008 /PRNewswire via COMTEX/ -- Dick Fosbury, gold medalist from the 1968 Olympic Games in Mexico City and innovator of the high jump technique dubbed the "Fosbury Flop," which revolutionized the sport and is now considered its standard, was stricken by cancer lymphoma in March. After undergoing surgery, radiation and chemotherapy treatment at the University of New Mexico Cancer Center, the State of New Mexico's Official Cancer Center based on the UNM campus in Albuquerque, NM, Fosbury is currently attending the 2008 Olympics Games in Beijing to celebrate the 40th anniversary of the "Fosbury Flop" and inspire cancer patients throughout the world.

LSU Health Sciences Center Inventor Awarded Patent for New Procedure to Detect Cancer Spread

NEW ORLEANS, June 24 (AScribe Newswire) -- Eugene A. Woltering, MD, FACS, The James D. Rives Professor of Surgery and Chief of the Sections of Surgical Oncology & Endocrine Surgery at LSU Health Sciences Center New Orleans, has been awarded a US Patent for a one-step method to rapidly identify "sentinel nodes;" the lymph nodes most likely to contain early metastasis from a primary cancer. Preliminary research indicates that the procedure which consists of injection of a radiolabeled dye around a cancer can identify sentinel nodes that receive lymphatic drainage from the tumor within 10 minutes. Dr. Woltering's patent is based on linking a radioactive iodine molecule to the blue dye commonly used in these sentinel node procedures. One of the major ways to determining the prognosis of a cancer involves determining whether the cancer has met

Genetic discovery may lead to blood test for families with high cancer risk

TORONTO - Canadian researchers have uncovered a genetic anomaly in people with a higher-than-normal risk of developing cancer that could lead to a blood test for detecting their tumours early, when the disease is most treatable.

Genetic discovery may lead to blood test for families with high cancer risk

TORONTO - Canadian researchers have uncovered a genetic anomaly in people with a higher-than-normal risk of developing cancer that could lead to a blood test for detecting their tumours early, when the disease is most treatable.

Search took 0.34 seconds.